Presentation TCT 2021 SURTAVI: Five-Year Results From a Randomized Trial of TAVR vs. SAVR in Patients at Intermediate Surgical Risk Presenter: Nicolas Van Mieghem November 05, 2021 REGISTER for free or LOG IN to view this content Structural Heart Aortic Valve TCT 2021 Up Next Presentation TCT 2021 TCT 103: Safety and Effectiveness of Transcatheter Edge-to-Edge Repair With MitraClip™ in Atrial Functional MR: An Analysis of the Global EXPAND Study Presenter: Nishtha Sodhi November 05, 2021 More slides + Presentation TCT 2021 TCT 102: Assessing the Risk of Neo-Left Ventricular Outflow Tract Obstruction in Transcatheter Mitral Valve Replacement: Are We Treating All the Patients That Can be Treated? Presenter: Keshav Kohli November 05, 2021 Presentation TCT 2021 RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration Presenter: Ajay Kirtane November 04, 2021 We Recommend
Presentation TCT 2021 TCT 103: Safety and Effectiveness of Transcatheter Edge-to-Edge Repair With MitraClip™ in Atrial Functional MR: An Analysis of the Global EXPAND Study Presenter: Nishtha Sodhi November 05, 2021
Presentation TCT 2021 TCT 102: Assessing the Risk of Neo-Left Ventricular Outflow Tract Obstruction in Transcatheter Mitral Valve Replacement: Are We Treating All the Patients That Can be Treated? Presenter: Keshav Kohli November 05, 2021
Presentation TCT 2021 RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration Presenter: Ajay Kirtane November 04, 2021